In this article, we discuss the top 5 stocks in Dov Gertzulin’s portfolio. If you wish to see our detailed analysis of Gertzulin’s history, investment philosophy, and hedge fund performance, go directly to Dov Gertzulin’s Portfolio: Top 10 Stocks.
5. Amarin Corporation plc (NASDAQ:AMRN)
DG Capital Management’s Stake Value: $18.97 million
Percentage of DG Capital Management’s 13F Portfolio: 4.09%
Number of Hedge Fund Holders: 21
Amarin Corporation plc (NASDAQ:AMRN) is a biotechnology company that focuses on developing and commercializing cost-effective therapies for patients.
As of Q2 2021, 21 hedge funds tracked by Insider Monkey have positions in Amarin Corporation plc (NASDAQ:AMRN), worth $298.4 million. The number of hedge funds that held stakes in the company for the first and second quarter of 2021 remained unchanged.
DG Capital Management reported holding over 4.3 million shares in Amarin Corporation plc (NASDAQ:AMRN), worth roughly $18.97 million.
On September 9, SVB Leerink analyst Roanna Ruiz initiated coverage of Amarin Corporation plc (NASDAQ:AMRN) with an Outperform rating and $12 price target.
4. Turning Point Brands, Inc. (NYSE:TPB)
DG Capital Management’s Stake Value: $19.63 million
Percentage of DG Capital Management’s 13F Portfolio: 4.25%
Number of Hedge Fund Holders: 30
Turning Point Brands, Inc. (NYSE:TPB) is a Kentucky-based tobacco company that manufactures, markets, and distributes smoking accessories and consumables.
Of the 873 elite funds being tracked by Insider Monkey, 30 held stakes in Turning Point Brands, Inc. (NYSE:TPB). Dov Gertzulin’s hedge fund currently holds 430,258 million shares in the company, amounting to more than $19.63 million in worth and representing 4.25% of his fund’s total portfolio value.
On October 28, B. Riley analyst Susan Anderson lowered the price target on Turning Point Brands, Inc. (NYSE:TPB) to $55 from $65 and reiterated a Buy rating on the shares of the company.
In the Q2 2021 investor letter of Kinsman Oak Capital Partners, the fund mentioned Turning Point Brands, Inc. (NYSE:TPB). Here is what the fund said:
“TPB continues to be a volatile stock, but business execution has been admirable since we first initiated our position. The company has put forth consecutive beat and raise quarters, announced a few tuck-in acquisitions, and recently promoted a new CFO. We view these developments as positives for the stock. We believe TPB remains undervalued at ~14x FY22 EPS and ~10x FY22 EBITDA.”
3. Everi Holdings Inc. (NYSE:EVRI)
DG Capital Management’s Stake Value: $23.2 million
Percentage of DG Capital Management’s 13F Portfolio: 5.01%
Number of Hedge Fund Holders: 31
Everi Holdings Inc. (NYSE:EVRI) is a global holding company. The company also manufacturers slot machines and offers financial equipment and services to casinos.
As of the end of the second quarter of 2021, 31 hedge funds out of the 873 tracked by Insider Monkey held stakes in Everi Holdings Inc. (NYSE:EVRI) worth roughly $319 million, up from 24 hedge fund in the preceding quarter.
According to the second quarter 13F Filings, DG Capital Management holds 932,524 shares in the company. These shares are valued at approximately $23.2 million.
Richard Driehaus of Driehaus Capital is the leading shareholder in the company, with over 1.8 million shares worth approximately $45.4 million.
2. Summit Materials Inc. (NYSE:SUM)
DG Capital Management’s Stake Value: $23.64 million
Percentage of DG Capital Management’s 13F Portfolio: 5.1%
Number of Hedge Fund Holders: 20
Summit Materials Inc. (NYSE:SUM) is an integrated materials-based company that supplies aggregates, cement, ready-mix concrete and asphalt in the United States.
Dov Gertzulin’s DG Capital Management currently holds 678,591 shares in Summit Materials Inc. (NYSE:SUM), amounting to over $23.64 million in worth and accounting for 5.1% of the investment firm’s portfolio. Overall, 20 funds were bullish on the company by the end of the June quarter, compared to 32 in the previous quarter.
On October 28, Wolfe Research analyst Timna Tanners initiated coverage of Summit Materials Inc. (NYSE:SUM) with an Outperform rating and $45 price target.
In the Q2 2021 investor letter of Carillon Tower Advisers, the fund mentioned Summit Materials, Inc. (NYSE:SUM). Here is what the fund had to say:
“Summit Materials is a vertically integrated construction materials-based company that supplies aggregates, cement, ready-mix concrete, and asphalt in the United States and British Columbia. The firm continues to benefit from recent migration trends that favor construction activity in the rural and exurban markets it primarily serves, allowing it to outpace the broader private construction markets. The potential extensive infrastructure plan recently proposed by the Biden administration could also provide an additional tailwind for future growth.”
1. United Therapeutics Corporation (NASDAQ:UTHR)
DG Capital Management’s Stake Value: $25.1 million
Percentage of DG Capital Management’s 13F Portfolio: 5.43%
Number of Hedge Fund Holders: 45
Coming in at first on our list of the top 10 stocks in Dov Gertzulin’s portfolio, United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company that is engaged in the manufacture of replacement organs and treatment for organ diseases.
Dov Gertzulin owns 140,299 shares in United Therapeutics Corporation (NASDAQ:UTHR), worth more than $25.1 million, representing 5.43% of his hedge fund’s investment portfolio. According to our database, 45 elite funds were bullish on the company at the end of June, up from 42 in the preceding quarter.
Jim Simons’ Renaissance Technologies is the leading shareholder in United Therapeutics Corporation (NASDAQ:UTHR), with over 3.1 million shares worth more than $557.9 million.
You can also take a look at 10 Stocks to Buy According to James Mitarotonda’s Barington Capital and Analysts are Cutting Price Targets of These 10 Stocks.
